Abbott plans to spin off its nutrition unit as a standalone public company

Go back to Abbott plans to spin off its nutrition unit as a standalone public company

Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company

October 21, 2026 7:25 AM EDT

Separation will unlock potential of both companies to pursue distinct growth and value-creation strategies The new Nutrition company will be a global leader in the rapidly growing healthy nutrition market, with a portfolio of iconic, category-leading brands, including Similac, PediaSure, Pedialyte, Glucerna and Ensure Abbott will have accelerated sales growth and an expanded margin profile Abbott intends to separate its Nutrition business through a tax-free distribution to Abbott shareholders Separation expected to be completed by the end of 2027

ABBOTT PARK,... More